Mesolimbic dopamine (DA) neurons play a central role in motivation and reward processing. Although the activity of these mesolimbic DA neurons is controlled by afferent inputs, little is known about the circuits in which they are embedded. Using retrograde tracing, electrophysiology, optogenetics, and behavioral assays, we identify principles of afferent-specific control in the mesolimbic DA system. Neurons in the medial shell subdivision of the nucleus accumbens (NAc) exert direct inhibitory control over two separate populations of mesolimbic DA neurons by activating different GABA receptor subtypes. In contrast, NAc lateral shell neurons mainly synapse onto ventral tegmental area (VTA) GABA neurons, resulting in disinhibition of DA neurons that project back to the NAc lateral shell. Lastly, we establish a critical role for NAc subregion-specific input to the VTA underlying motivated behavior. Collectively, our results suggest a distinction in the incorporation of inhibitory inputs between different subtypes of mesolimbic DA neurons.
In Brief
The mesolimbic dopamine system plays an important role in motivated behaviors, reinforcement learning, and reward processing. Yang et al. identify new functional and organizational principles of afferent-specific control in mesolimbic dopamine neurons that are critical for appetitive behaviors.
INTRODUCTION Dopamine (DA) projections from the ventral tegmental area (VTA) to the nucleus accumbens (NAc), which comprise the mesolimbic DA system (Bjö rklund and Dunnett, 2007; Ikemoto, 2007; Morales and Margolis, 2017) , play an important role in motivated behaviors, reinforcement learning, and reward processing (Hamid et al., 2016; Salamone and Correa, 2012; Schultz, 2016; Watabe-Uchida et al., 2017) . Dysfunction of this system has been implicated in neuropsychiatric disorders such as substance abuse disorder (Ikemoto and Bonci, 2014; L€ uscher, 2016) and depression (Nestler and Carlezon, 2006) . While this has led to intense study into DA neurotransmission and the influence of DAergic input to the NAc on motivated behaviors, much less is known about the architecture and function of inhibitory feedback projections from the NAc to the VTA.
It is estimated that 50%-70% of all afferents to DA neurons are GABAergic and these inhibitory inputs have a major impact on the activity of DA neurons (Henny et al., 2012) . Indeed, the removal of tonic inhibition from VTA DA neurons is considered an important candidate mechanism by which DA neurons may encode reward-related bursting (Paladini and Roeper, 2014; Watabe-Uchida et al., 2017) and by which drugs of abuse may cause increases in DA neuron activity (Ikemoto and Bonci, 2014; L€ uscher, 2016) . While direct inhibitory afferents to VTA DA neurons arise from a number of structures (Matsui et al., 2014) , recent anatomical studies have shown that the NAc is a major source of such GABAergic input Watabe-Uchida et al., 2012) . By contrast, studies combining electrophysiology and optogenetic manipulations have failed to provide robust evidence for the existence of a direct inhibitory pathway from the NAc to DA neurons, suggesting that NAc inputs instead regulate VTA DA neurons through disinhibition (Bocklisch et al., 2013; Chuhma et al., 2011; Xia et al., 2011) . Recently, Edwards and colleagues addressed these conflicting results by demonstrating that NAc neurons synapse onto both VTA GABA and DA neurons via selective activation of different GABA receptor subtypes (GABA A and GABA B , respectively) (Edwards et al., 2017) . However, questions about this circuit remain, as previous studies did not find evidence for GABA B receptor activation in VTA DA neurons in response to NAc stimulation (Xia et al., 2011) . In addition, electrical stimulation of the striatum has been shown to induce inhibitory responses with very short latencies in DA neurons that are blocked by GABA A but not GABA B receptor antagonists, which hints at the presence of a direct pathway mediated by GABA A receptors instead (Paladini et al., 1999) .
Concurrently with these studies, evidence has emerged suggesting that VTA DA neurons represent anatomically and functionally distinct populations, which project to different NAc subdivisions (medial shell (NAcMed), lateral shell (NAcLat), core) and receive highly biased inputs from separate ventral striatal subregions Lammel et al., 2008 Lammel et al., , 2012 . Because NAc subdivisions can exert opposing influences on motivated behaviors (Aragona et al., 2008; Bassareo et al., 2002; Berridge and Kringelbach, 2015; Dreyer et al., 2016; Salamone and Correa, 2012) and subpopulations of VTA DA neurons presumably transmit different signals within these structures (Bromberg-Martin et al., 2010; Fields et al., 2007; Ikemoto, 2007; Lammel et al., 2014; Roeper, 2013) , we hypothesized that separate NAc subdivisions are embedded into distinct VTA subcircuits. Determining the connectivity and function of distinct NAc inputs to the VTA would represent a critical step toward understanding the functional heterogeneity of VTA DA neurons and their role in motivated behaviors.
RESULTS

Anatomical Organization of NAcMed and NAcLat Inputs to the VTA
The NAc is composed of anatomically and functionally distinct subregions (medial shell [NAcMed] , lateral shell [NAcLat] , and core) and provides one of the most prominent projections to the VTA (Groenewegen et al., 1999; Ikemoto, 2007; WatabeUchida et al., 2012) . We first characterized the anatomical organization of projections from the NAcMed and NAcLat to the VTA. We focused on the NAcMed and NAcLat since VTA DA neurons projecting to these regions demonstrate very different anatomical, molecular, and electrophysiological properties . Importantly, we could selectively express viral vectors in these areas without cross-contamination.
The principal cell types in the NAc are GABAergic medium spiny neurons (MSNs), which are divided into two groups based on their preferential expression of either D1-or D2-type DA receptors (Gerfen and Surmeier, 2011; Kupchik et al., 2015) . Previous work has shown that D1-but not D2-expressing MSNs project to the VTA (Bocklisch et al., 2013; Edwards et al., 2017; Kupchik et al., 2015) . To examine the innervation patterns from distinct NAc subdivisions, we targeted adeno-associated viruses (AAVs) containing a double-floxed, inverted open reading frame for enhanced yellow fluorescent protein (AAV-DIO-eYFP) or mCherry (AAV-DIO-mCherry) to the NAcMed and NAcLat of the same D1-Cre mouse, respectively (Figures 1A and 1B) . 6-8 weeks later, we sectioned the midbrain and observed that NAcMed and NAcLat terminals were located in different VTA subregions ( Figure 1C ). eYFP-expressing NAcMed terminals were predominantly located in the medial VTA (mVTA; paranigral (red, 546 nm) in the NAcLat of a D1-Cre mouse. Blue staining represents DAPI (LV, lateral ventricle; aca, anterior commissure; CPu, caudate putamen; LS, lateral septum; Pir, piriform cortex; scale bar, 100 mm). (C) Confocal image of a coronal midbrain section showing TH-immunostaining (blue, 647 nm) with eYFP-expressing NAcMed terminals in the medial VTA (mVTA) and mCherry-expressing NAcLat terminals in the lateral VTA (lVTA; IPN, interpeduncular nucleus; ml, medial lemniscus; scale bar, 100 mm). (D) Confocal images showing dense clustering of eYFP-expressing NAcMed terminals in close proximity of DA neurons in the mVTA (1). mCherry-expressing NAcLat terminals are less frequently observed near DA neurons in the lVTA (2; scale bars, 50 mm). (E) Bar graphs showing differences in fluorescence intensity for NAcMed and NAcLat terminals in different VTA subregions (*p < 0.05, **p < 0.01) (data represent means ± SEM). (F) Schematic overview demonstrating matching projection patterns between NAc and VTA subregions. nucleus and interfascicular nucleus), in close proximity to tyrosine hydroxylase (TH)-immunopositive neurons (i.e., DAergic neurons), and eYFP fluorescence levels were significantly higher in the mVTA compared to the lateral VTA (lVTA; lateral parabrachial nucleus). By contrast, NAcLat terminals were located mainly in the lVTA, with only a few NAcLat terminals near TH-immunopositive neurons, and fluorescence levels were significantly higher in the lVTA compared to the mVTA (Figures 1D and 1E; NAcMed: mVTA: 5.19% ± 0.75%, lVTA: 0.17% ± 0.03%, p = 0.0026; NAcLat: mVTA: 0.18% ± 0.06%, lVTA: 3.18% ± 0.84%, p = 0.0237; n = 3 mice). We also tested whether D2 MSNs, which selectively express adenosine2a (A2a) receptors, in the two NAc subdivisions project to the VTA. We injected AAVs conditionally expressing the two fluorophores into the NAcMed and NAcLat of A2a-Cre mice (Figures S1A and S1B) . In this case, we did not detect eYFP or mCherry terminal expression in the VTA ( Figure S1C ). This distinct anatomical localization between NAcMed and NAcLat terminals in VTA subregions, which are known to contain different mesolimbic DA subtypes , suggests that the mesolimbic DA system comprises parallel reciprocal subcircuits ( Figure 1F ).
Mesolimbic DA Subpopulations Are Embedded within Distinct Inhibitory Networks
The segregated inputs from NAcMed and NAcLat to different subregions of the VTA indicate that inhibitory inputs to DA neurons in these subregions may be functionally distinct. To investigate this, we carried out dual retrograde tracing experiments by injecting green fluorescent retrobeads into NAcMed and red retrobeads into NAcLat into the same mouse and performed slice electrophysiology experiments (Figures 2A and 2B ). Consistent with previous data , we found that NAcLat-projecting DA neurons (identified by positive TH-immunoreactivity and red retrobead labeling) were located predominantly in the lVTA, while NAcMed-projecting DA neurons (TH-immunopositive and green retrobead labeling) clustered in the mVTA ( Figure 2C ). We then recorded miniature inhibitory postsynaptic currents (mIPSCs) from these two DA subpopulations ( Figure 2D ). Although no significant differences were observed in the amplitude of mIPSCs ( Figure 2E ; NAcLat-proj.: 42.77 ± 4.24 pA, n = 8; NAcMed-proj.: 38.18 ± 3.95 pA, n = 8; p = 0.4414), we found that the mIPSC frequency was significantly higher in NAcLat-compared to NAcMed-projecting VTA DA neurons ( Figure 2F ; NAcLat-proj.: 5.24 ± 0.63 Hz, n = 8; NAcMed-proj.: 1.22 ± 0.28 Hz, n = 8; p < 0.0001) indicating that inhibitory input differs remarkably between mesolimbic DA subpopulations. These findings are in agreement with a recent anatomical study, which reported that VTA DA neurons receive differential inputs from many brain structures known to have GABAergic projection neurons, including distinct NAc subdivisions .
NAcLat Inputs Promote Disinhibition of NAcLatProjecting VTA DA Neurons We next combined optogenetics and slice electrophysiology to test whether distinct NAc subregions directly target different mesolimbic DA subpopulations. We first expressed channelrhodopsin-2 (ChR2) in the NAcLat and injected red fluorescent retrobeads into the NAcLat and NAcMed of the same animal ( Figure 3A) . We used the same fluorophore (i.e., rhodamine) to label both NAcMed-and NAcLat-projecting VTA DA neurons since green retrobeads would overlap with the ChR2-eFYP signal. We were able to reliably differentiate the two subtypes as they are located in different VTA subregions ( Figure 2C ; Lammel et al., 2008 Lammel et al., , 2011 Lammel et al., , 2012 and have different electrophysiological properties . Using this approach, we could directly compare the synaptic strength and connectivity of NAc inputs to the two mesolimbic DA subpopulations. We recorded light-evoked inhibitory postsynaptic currents (IPSCs) from retrogradely labeled NAcMed-and NAcLat-projecting VTA neurons and verified the DA phenotype through post hoc TH-immunohistochemistry of neurobiotin (NB)-filled cells ( Figure S2A ). We found that relatively few NAcMed-projecting DA neurons responded to light stimulation (20.6%, n = 7/34 cells), while the majority of cells that responded to light stimulation were NAcLat-projecting DA neurons (61.5%, n = 24/39 cells), and their mean amplitude was not significantly different ( Figure 3B ; n = 24; n = 7; p = 0.5879) . Notably, light-evoked IPSCs were strongly reduced by 50 mM picrotoxin (PCTX), indicating the presence of a weak but direct GABA A receptor (GABAAR)-mediated connection between the NAcLat and NAcLat-projecting DA neurons ( Figure 3C ; control: 235.7 ± 75.29 pA; PCTX: 54.35 ± 16.01 pA, n = 10; p = 0.0173). Because previous work suggested that the NAc mainly targets VTA GABA neurons (Bocklisch et al., 2013; Chuhma et al., 2011; Xia et al., 2011) , we performed another series of experiments in which we compared light-evoked IPSCs between NAcLat-projecting DA neurons and non-DA (i.e., TH-immunonegative, no retrobead labeling) neurons in the VTA. In this case, we found that the mean IPSC amplitude was significantly larger in non-DA neurons compared to NAcLat-projecting DA neurons ( Figure 3D ; NAcLat-proj.: 305.2 ± 64.42 pA, n = 13; non-DA.: 1,675 ± 526 pA, n = 5; p = 0.0007). Our connectivity experiments revealed that NAc-Lat-projecting DA neurons and non-DA neurons both receive inhibitory inputs from NAcLat MSNs, with non-DA neurons receiving stronger inhibition on average. In order to determine the net effect of NAcLat MSN inputs on DA neuron activity, we recorded spontaneous firing of NAcLat-projecting DA neurons in the whole-cell current-clamp configuration while optogenetically stimulating NAcLat terminals (20 Hz). We observed a significant increase in firing in response to NAcLat terminal stimulation in 90% of the recorded cells ( NAcMed Inputs Directly Inhibit NAcMed-Projecting VTA DA Neurons To investigate the consequences of activating NAcMed inputs to the VTA, we expressed ChR2 in the NAcMed and injected red retrobeads into NAcLat and NAcMed of the same animal and recorded from different mesolimbic DA subpopulations in the VTA (Figures 3G and S2B) . Surprisingly, we detected large lightevoked IPSCs in 83% (n = 15/18 cells) of NAcMed-projecting DA neurons that were blocked by PCTX ( Figures 3H and 3I , control: 1,508 ± 324.9 pA; PCTX: 235 ± 68.5 pA, n = 6; p = 0.0129), suggesting the existence of a strong monosynaptic connection between the NAcMed and NAcMed-projecting DA neurons that is mediated by GABAARs. In fact, the mean IPSC amplitude was over four times larger than the relatively weak direct reciprocal connectivity of the NAcLat pathway. By contrast, the proportion of NAcLat-projecting DA neurons receiving NAcMed input was substantially lower (19%, n = 7/36 cells) and their mean IPSC amplitude was significantly smaller compared to NAcMed-projecting DA neurons ( Figure 3H 
(legend continued on next page)
NAcLat-proj.: 357.7 ± 74.89 pA, n = 7; p = 0.018). We also detected light-evoked IPSCs in non-DA neurons in the VTA. Their mean IPSC amplitude was not significantly different from NAcMed-projecting DA neurons ( Figure 3J ; NAcMed-proj.: 639.1 ± 175.3 pA, n = 10; non-DA: 1291 ± 470.9 pA, n = 7; p = 0.161). Lastly, spontaneous firing of the majority (>70%) of NAcMed-projecting DA neurons was inhibited by 20 Hz optogenetic stimulation of NAcMed terminals in the VTA (Figures 3K  and 3L ; off: 1.48 ± 0.22 Hz; 20 Hz: 0.71 ± 0.24 Hz, off: 1.43 ± 0.24 Hz, n = 17; RM one-way ANOVA, p off versus on = 0.0258, p off versus off = 0.9054, p on versus off = 0.0298). Combined, these results suggest that NAcMed inputs preferentially exert direct inhibitory control over non-DA neurons, and over NAcMed-projecting DA neurons, and that the latter inhibition is mediated by GABAARs.
NAcLat Inputs to VTA GABA Neurons Are Stronger than NAcMed Inputs Both NAcLat and NAcMed make robust synaptic connections onto non-DA neurons in the VTA ( Figures 3D and 3J ). Because the VTA contains heterogeneous populations of DAergic, GABAergic, and glutamatergic neurons (Fields et al., 2007; Lammel et al., 2014; Morales and Margolis, 2017) , we next investigated the synaptic connectivity between NAcLat and NAcMed and genetically identified VTA GABA neurons. To do this, we expressed ChR2 in the NAcLat or NAcMed of GAD2::tdTomato (GAD2-tdT) mice and recorded light-evoked IPSCs in GAD2-tdT-positive neurons throughout the VTA ( Figure S2C ). We detected robust light-evoked IPSCs in GAD2-tdT-positive neurons in response to both NAcMed and NAcLat terminal stimulation; however, connections from NAcLat to VTA GAD2-tdT-positive neurons were significantly stronger and caused larger IPSCs (Figures S2D and S2E ; NAcLat: 1,665 ± 365.2 pA, n = 23; NAcMed: 734.6 ± 223.24 pA, n = 23; p = 0.0352). Importantly, response rates were higher when we recorded GAD2-tdT-positive neurons in a VTA subregion that was matched with the corresponding NAc subdivision, i.e., mVTA for NAcMed and lVTA for NAcLat terminal stimulation ( Figure S2F ; NAcMed: mVTA: 92%, n = 12/13 cells, lVTA: 46%, n = 11/24 cells; NAcLat: mVTA: 36%, n = 4/11 cells, lVTA: 79%, n = 19/24 cells), consistent with the subregion-specific location of NAcMed and NAcLat terminals in the VTA (Figures S2G and S2H) .
Given the subregion-specific innervation of VTA GABA neurons by the NAc, we next asked whether there are differences in their inhibitory synaptic control over NAcMed-and NAcLatprojecting DA neurons. To investigate this, we injected AAV-DIO-ChR2 into the VTA of GAD2-Cre mice and recorded from retrogradely labeled NAcMed-and NAcLat-projecting DA neurons ( Figure S2I ). Optogenetic stimulation of VTA GABA neurons evoked GABAAR-mediated IPSCs in both NAcMed-and NAcLat-projecting DA neurons. However, IPSCs were significantly larger in NAcLat-projecting DA neurons than in NAcMed-projecting DA neurons ( Figure S2J ; NAcMed-proj.: 628.6 ± 111.5 pA, n = 13; NAcLat-proj.: 1,516 ± 195.8 pA, n = 11; p = 0.0005). Together, these findings suggest that NAcMed and NAcLat projections form distinct inhibitory subcircuits in the VTA incorporating different populations of GABAergic and mesolimbic DA neurons with opposing effects on the net activity of VTA DA neurons.
Optogenetic Control of NAcLat and NAcMed Inputs to VTA in Freely Moving Mice DA neurons in the lVTA form a largely homogeneous cell population that promotes reward and reinforcement (Eshel et al., 2016; Schultz, 2016; Steinberg and Janak, 2013) and activation of NAcLat inputs to the VTA results in disinhibition of lVTA DA neurons ( Figures 3D-3F ). Thus, we hypothesized that activation of NAcLat terminals in the VTA produces reward-related behaviors. To test our prediction, we injected AAV-DIO-ChR2 or a control vector, AAV-DIO-eYFP, into the NAcLat of D1-Cre mice, implanted an optical fiber above the VTA, and performed a realtime place preference assay ( Figures 4A, 4B , and S3). Consistent with our anatomical characterization of NAcLat inputs (Figure 1 ), we observed ChR2-expressing NAcLat terminals mainly in the lVTA ( Figure 4C ). The results from our behavioral experiments were consistent with our hypothesis. Optogenetic stimulation of NAcLat inputs in the VTA caused robust real-time place preference, where animals spent significantly more time in the compartment where they received light stimulation and less time in the compartment where they did not receive stimulation. Indeed, switching the stimulation to the originally non-stimulated compartment caused immediate reversal of compartment preference (Figures 4D-4F ; non-stim.: 184.4 ± 27.16 s, stim.: 894.9 ± 40.69 s, n = 9; p < 0.0001). We also observed a significant increase in the total number of entries into the stimulated compartment ( Figure 4G ; non-stim.: 14 ± 1.19, stim.: 32.22 ± 4.54, n = 9; p = 0.0038). Mice that received injection of the control vector (AAV-DIO-eYFP) into the NAcLat spent equal amounts of time on either side of the chamber (data not shown). Furthermore, activation of NAcLat VTA inputs supported robust reinforcement in an intracranial self-stimulation task where mice could respond at a nosepoke port to obtain stimulation (Figure 4H ; ChR2: 1,523 ± 316.4, n = 9, eYFP: 25.5 ± 7.84, n = 6; p = 0.0021). Optogenetic stimulation of NAcLat inputs had no significant effect on either anxiety-related behavior assessed in the elevated plus maze ( Figure 4I ; off: 9.11 ± 2.64 s, on: 3.32 ± 0.97 s, off: 10.47 ± 4.37 s, n = 8; RM one-way ANOVA, p off versus on = 0.2473, p on versus off = 0.9662, p off versus off = 0.2688) or general locomotor activity assessed in the open field test ( Figure S4A ). Next, we sought to test whether silencing 
NAcLat terminals in the VTA influences place preference behavior and hypothesized that this manipulation will induce aversion behavior. We observed a small but not significant effect on place avoidance behavior when inhibiting NAcLat terminals in the VTA using an inhibitory opsin (halorhodopsin, eNpHR3.0; Figure S5 ). Such a weak effect is surprising given that we had initially observed a strong and robust effect when driving NAcLat terminals in the VTA using ChR2. While these negative results could imply that NAcLat inputs to the VTA are not causally involved in this behavior, we think that this is relatively unlikely because of potential difficulties in generating changes in neurotransmitter release with terminal inhibition (Howe and Dombeck, 2016; Mahn et al., 2016) . Thus, it is likely that the inability to suppress a large enough portion of NAcLat terminals in the VTA contributes to the lack of place aversion behavior in this experiment. We next investigated the functional role of NAcMed inputs to the VTA by injecting AAV-DIO-ChR2 or AAV-DIO-eYFP into the NAcMed of D1-Cre mice and implanting an optical fiber above the VTA ( Figures 5A , 5B, and S3). As expected, ChR2-expressing NAcMed terminals were located mainly in the mVTA (Figure 5C ). Based on our finding that NAcMed inputs exert strong inhibitory influence over NAcMed-projecting DA neurons (Figures 3K and 3L) , we predicted that optogenetic stimulation of NAcMed inputs will induce aversion. Surprisingly, optogenetic stimulation of NAcMed inputs elicited neither immediate aversion nor preference and did not support intracranial self-stimulation (Figures 5D-5G ; place preference: non-stim.: 350.6 ± 53.74 s, stim.: 325.8 ± 35.59 s, n = 10; p = 0.6897; self-stimulation: ChR2: 45 ± 6.06, n = 10, eYFP: 32.33 ± 5.8, n = 6; p = 0.184). Instead, we observed that after switching the stimulation to the original non-stimulated compartment in our threechamber place preference assay, the mice showed a strong preference for the neutral area ( Figures 5D and 5E ). In fact, the total time spent in the neutral area was significantly higher when compared to control animals or in response to optogenetic stimulation of ChR2-expressing NAcLat inputs ( Figure 5H ; NAcMed: ChR2: 523.5 ± 68.58 s, n = 10, eYFP: 293.5 ± 64.55 s, n = 6; NAcLat: ChR2: 82.53 ± 9.02 s, n = 9, eYFP: 304.9 ± 42.22 s; n = 8; two-way ANOVA [interaction], p = 0.0002; NAcMed p = 0.0097, NAcLat p = 0.0097). Although arguments can be made that the increase in time spent in the neutral area reflects aversion, this phenotype was clearly different from the aversion previously observed in response to optogenetic stimulation of lateral habenula (LHb) inputs to the VTA Stamatakis and Stuber, 2012) . Optogenetic stimulation of NAcMed inputs had no acute effect on anxiety or locomotion, but we noticed that immediately after turning off light stimulation, the mice showed increased anxiety levels ( Figure 5I ; off: 10.52 ± 3.83 s, on: 9.52 ± 3.38 s, off: 1.9 ± 1.1 s, n = 10; RM one-way ANOVA, p off versus on = 0.9191, p off versus off = 0.0664, p on versus off = 0.0484) and a reduction in general locomotor activity ( Figure S4B ). These effects were not observed in the control group (eYFP; data not shown) or in response to NAcLat ( Figures 4I and S4A) or LHb terminal stimulation in the VTA.
Thus, optogenetic stimulation of VTA afferents that originate from distinct NAc subnuclei induces distinct behavioral phenotypes. Activation of NAcLat inputs resulted in a robust reinforcement phenotype, while stimulation of NAcMed terminals produced a subsequent, generalized state of behavioral suppression that followed the stimulation period, and this was not specific to reward or to aversion.
NAcMed Inputs Control NAcLat-Projecting DA Neurons via GABA B Receptors
The observation that optogenetic stimulation of NAcMed inputs does not promote reward or aversion is puzzling. We revisited the literature in light of our unexpected behavioral findings to look for something that could explain this discrepancy. GABAergic inhibition of VTA DA neurons is mediated by both fast ionotropic GABAARs and slow metabotropic GABA B receptors (GABABRs) (Cruz et al., 2004; Labouè be et al., 2007) . A recent study showed that NAc inputs to the VTA inhibit the firing of DA neurons in the lVTA through specific activation of GABABRs (Edwards et al., 2017) . Based on these findings, we speculated that NAcMed inputs do not only inhibit NAcMed-projecting DA neurons through GABAARs ( Figures 3H and 3I ), but they may also activate GABABRs in NAcLat-projecting DA neurons in the lVTA. Thus, the behavioral phenotype we observed in response to NAcMed terminal stimulation in the VTA ( Figure 5 ) may involve inhibition of mesolimbic DA subpopulations through separate GABA receptor classes.
Because relatively little is known about GABABR-mediated function in projection-defined DA subpopulations, we first examined the effects of GABABR-activation in NAcLat-and NAcMedprojecting DA neurons ( Figure 6A ). To do this, we performed whole-cell recordings from the two mesolimbic subtypes and bath applied the GABABR agonist baclofen (p-chlorophenyl-GABA). As shown previously for I h -positive VTA DA neurons (Cruz et al., 2004; Labouè be et al., 2007) , we found that application of 100 mM baclofen evoked robust outward currents in bead-labeled NAcLat-projecting DA neurons that correlated with a decrease in input resistance (data not shown), showed a characteristic acute desensitization and was inhibited with a GABABR antagonist (100 mM CGP35348). In contrast, baclofen-activated currents were significantly smaller in NAcMed-projecting DA neurons (Figures 6B and 6C ; NAcLat-proj.: 102.4 ± 20.59 pA, n = 7; NAcMed-proj.: 12.95 ± 5.06 pA, n = 6; p = 0.0024). The VTA also contains glutamatergic neurons, and co-expression of glutamatergic markers (i.e., VGLUT2) has been reported in DA neurons (Morales and Margolis, 2017) . Interestingly, we found that VGLUT2 is predominantly co-expressed (H) Bar graph showing that mice receiving optogenetic stimulation of NAcMed terminals in the VTA spent significantly more time in the neutral compartment compared to eYFP-expressing animals or mice that express ChR2 or eYFP in NAcLat terminals (*p < 0.05, ***p < 0.001) (data represent means ± SEM). in NAcMed-projecting DA neurons but can only be detected in very few NAcLat-projecting DA neurons (Figures S6A-S6F) . To investigate the possibility of GABABR-mediated transmission in VTA glutamatergic neurons, we performed whole-cell patchclamp recordings from VTA glutamatergic neurons (i.e., VGLUT2+ THÀ) and VGLUT2-coexpressing VTA DA neurons (i.e., VGLUT2+ TH+) and applied 100 mM baclofen ( Figures  S6G-S6K) . We found that baclofen-evoked peak outward currents in these two cell populations were comparable to currents observed in NAcMed-projecting DA neurons, but $3-5 times smaller than in NAcLat-projecting DA neurons ( Figures S6H  and S6I ).
To examine afferent-specific GABABR-mediated currents, we injected AAV-DIO-ChR2 into the NAcMed of D1-Cre mice and performed whole-cell recordings from NAcLat-and NAcMedprojecting DA neurons ( Figure 6D ). In voltage clamp, trains of stimuli (20 Hz, 20 pulses) produced slow light-evoked IPSCs in NAcLat-projecting DA neurons in 18 out of 34 recorded cells. The IPSCs had a similar waveform as the GABABR-mediated IPSCs observed by (Edwards et al., 2017) and were blocked by bath application of 100 mM CGP35348 (Figures 6E and 6F ; ACSF [artificial cerebrospinal fluid]: 13.24 ± 2.57 pA, n = 18; CGP35348: 0.3 ± 0.11 pA, n = 8; p = 0.0028). In addition, 20 Hz light stimulation of NAcMed terminals reduced spontaneous firing of NAcLat-projecting DA neurons in 7 out of 20 recorded cells, which was blocked by bath application of 100 mM CGP35348 ( Figure 6G ; off: 0.54 ± 0.08 Hz; ACSF: 0.15 ± 0.04 Hz; CGP: 0.65 ± 0.1 Hz, n = 7; RM one-way ANOVA, p off versus ACSF = 0.0066, p off versus CGP = 0.4306, p ACSF versus CGP = 0.0081). In contrast, light stimulation of NAcMed terminals generally failed to produce slow light-evoked IPSCs in NAcMed-projecting DA neurons ( Figure 6E ; only 1 out of 15 recorded cells produced an 8.1 pA response) and bath application of 100 mM CGP35348 did not influence the inhibition of spontaneous firing evoked by NAcMed terminal stimulation in these cells ( Figure 6H ; off: 1.42 ± 0.16 Hz; ACSF: 0.29 ± 0.21 Hz; CGP: 0.3 ± 0.18 Hz, n = 10; RM one-way ANOVA, p off versus ACSF = 0.0004, p off versus CGP = 0.0004, p ACSF versus CGP = 0.994). No slow light-evoked GABABR-mediated responses were detected in either NAcLat-or NAcMed-projecting DA neurons when ChR2 was expressed in the NAcLat (Figures S7A and S7B) and bath application of 100 mM CGP35348 did not influence the effects of light stimulation of NAcLat terminals on spontaneous firing of NAcLat-and NAcMed-projecting DA neurons ( Figures S7C  and S7D ). Together, these findings indicate that D1 MSNs in the NAcMed selectively inhibit NAcLat-projecting DA neurons through GABABR activation.
The ability to elicit GABABR-mediated responses in NAcLatprojecting DA neurons ( Figures 6E and 6F ) and GABAAR-mediated responses in NAcMed-projecting DA neurons (Figures 3B and 3C) suggests that the behavioral phenotype we observed in response to NAcMed terminal stimulation ( Figure 5 ) might be due to a strong overall suppression of both mesolimbic subsystems. To formally test this possibility, we expressed ChR2 in the NAcMed of D1-Cre mice and implanted opto-fluid cannulas, which allow both light stimulation and infusion of fluids, just dorsal to the VTA (Figures 7A and S8) . We then optogenetically stimulated NAcMed inputs in a real-time place preference assay, but 3 min before the experiment we infused either ACSF or the GABABR antagonist CGP35348 into the VTA ( Figure 7B ). Infusion of ACSF resulted in the same behavior that we observed previously ( Figure 7C ; non-stim.: 365.3 ± 28.30 s, stim. side: 439.7 ± 72.11 s, n = 6; p = 0.4353). In contrast, infusion of 15 nM CGP35348 produced place preference behavior in all mice tested ( Figure 7D ; non-stim.: 296.8 ± 42.61 s, stim.: 617.8 ± 55.76 s, n = 6; p < 0.0001). Moreover, CGP35348 infusion also prevented the increase in anxiety behavior which we observed immediately after turning off light stimulation in ACSF-treated animals (Figures 7E and 7F ; ACSF: off: 31.93 ± 9.5 s, on: 32.07 ± 7.86 s, off: 8.6 ± 4.41 s; n = 6; RM oneway ANOVA, p off versus on = 0.9996, p off versus off = 0.0203, p on versus off = 0.0219; CGP35348: off: 46.4 ± 18.48 s, on: 32.85 ± 9.37 s, off: 54.08 ± 22.87 s, n = 6; RM oneway ANOVA, p off versus on = 0.4417, p off versus off = 0.5688, p on versus off = 0.435). Together, these findings reveal a subcircuit for motivated behaviors that involves D1 MSNs in the NAcMed, which selectively inhibit distinct mesolimbic DA subpopulations through different classes of GABA receptors.
DISCUSSION
Here, we have used a multidisciplinary approach combining retrograde tracing, electrophysiology, optogenetics, and behavioral assays to elucidate the circuit architecture and function of reciprocal connectivity in the mesolimbic DA system. A prominent finding of our study is that D1-expressing MSNs in the NAcMed exert direct inhibitory control over two distinct mesolimbic DA subpopulations by activating separate GABA receptor subtypes. Specifically, D1-expressing MSNs in the NAcMed preferentially inhibit NAcMed-projecting DA neurons via GABAAR and NAcLat-projecting DA neurons via GABABR. In contrast, D1-expressing MSNs in the NAcLat mainly synapse onto VTA GABA neurons resulting in a disinhibition of NAcLatprojecting DA neurons (Figure 8) . Moreover, using in vivo optogenetic manipulations, we established a critical role for NAc subregion-specific inputs to the VTA in regulating motivated behaviors.
Our findings help to solve an ongoing controversy regarding the connectivity of the NAc with VTA subpopulations. While recent anatomical studies suggest that the largest proportion of monosynaptic inputs to VTA DA neurons originates from the NAc Faget et al., 2016; Watabe-Uchida et al., 2012) , which is mainly composed of GABAergic MSNs, studies combining electrophysiology and optogenetic manipulations have failed to provide compelling evidence for the existence of a direct inhibitory synaptic connection to DA neurons (Bocklisch et al., 2013; Chuhma et al., 2011; Xia et al., 2011) . However, in light of mounting evidence pointing to anatomical and functional heterogeneity between subpopulations of VTA DA neurons, a major limitation of these functional studies is that the connection between the NAc and VTA neurons has been investigated in the absence of subregion and/or projection specificity. It is likely that these studies focused on NAcMed inputs to I h -positive DA neurons in the lateral VTA, which indeed are very sparse compared to NAcMed inputs to NAcMed-projecting DA neurons. By differentiating VTA DA neurons based on their specific afferent and efferent connectivity, we were able to confirm a striking reciprocal connectivity between the NAcMed and its DAergic inputs, thereby mirroring the results of recent transsynaptic rabies virus tracing studies Faget et al., 2016; Watabe-Uchida et al., 2012) . Thus, our results bridge the gap between previously confounding electrophysiological and anatomical studies that have controversially discussed the existence of direct monosynaptic connections between the NAc and VTA DA neurons.
Our input-and projection-specific optogenetic experiments not only provide functional information about connection probability and strength between distinct NAc subregions and VTA subpopulations, but also help to elucidate the specific contribution of GABAARs and GABABRs in these pathways. The prevailing view is that GABAAR activation (e.g., through infusion of muscimol into the VTA or optogenetic activation of VTA GABA neurons) results in increased firing of VTA DA neurons through disinhibition (Bocklisch et al., 2013; Kalivas et al., 1990; Klitenick et al., 1992; Tan et al., 2012; van Zessen et al., 2012) . Nevertheless, several studies observed ''paradoxical'' effects in response to GABAAR activation that resulted in decreased DA transmission (Ikemoto et al., 1998; Westerink et al., 1996) . Such results may reflect dose-dependent effects due to differences in sensitivity of GABAARs on VTA DA and GABA neurons (Doherty and Gratton, 2007) or, based on our data, on GABAAR activation in different mesolimbic subsystems. Accordingly, VTA GABAAR activation could result in an increase in DA transmission in the NAcLat via disinhibition of NAcLat-projecting DA neurons and a decrease in DA transmission in the NAcMed due to direct suppression of DA neurons projecting to NAcMed. It has been suggested that within the VTA, GABAARs and GABABRs are anatomically and functionally dissociable (Cameron and Williams, 1993; Doherty and Gratton, 2007; Klitenick et al., 1992; Laviolette and van der Kooy, 2001; Panagis and Kastellakis, 2002; Sugita et al., 1992; Xi and Stein, 1998) . This widely held assumption has gained momentum with a recent study showing that NAc neurons inhibited VTA GABA neurons through GABAARs and inhibited VTA DA neurons via GABABRs (Edwards et al., 2017) . Our data are consistent with this finding, yet it shows that our perspective of GABA signaling in the VTA needs to be more nuanced; specifically, limiting GABAAR and GABABR-mediated actions to VTA GABA neurons and DA neurons, respectively, is an oversimplification. In contrast, we find distinct GABAAR-mediated pathways that originate from discrete NAc subregions and target specific VTA DA and GABA subpopulations. Such parallel channels for information flow are reminiscent of the parallel nigrostriatal DA subcircuits recently described for different subregions of the substantia nigra (Lerner et al., 2015) . Nevertheless, NAcMed and NAcLat do not exclusively form parallel pathways to the VTA. We also found that there is remarkable cross communication between these systems; in addition to targeting NAcMed-projecting DA neurons via GABAARs, the NAcMed also exert strong inhibitory influence over NAcLat-projecting DA neurons that is mediated through GABABR activation. It is currently unknown whether these inputs originate from the same D1-expressing MSNs or from separate cell populations, and whether neurons in the NAcMed and NAcLat directly communicate with each other. However, the information flow from medial to lateral described here for the mesolimbic DA system and in Lerner et al. (2015) for the nigrostriatal DA system provides new insights into the ascending spiral model originally described by Haber et al. (2000) .
What is the functional role of NAc inputs to the VTA? The removal of tonic inhibition from VTA GABA neurons onto DA neurons is a critical candidate mechanism by which DA neurons could encode reward-related bursting (Paladini and Roeper, 2014; Watabe-Uchida et al., 2017) and by which drugs of abuse exert maladaptive increases in DA neuron activity (Ikemoto and Bonci, 2014; L€ uscher, 2016) . Given that the NAc is a major source of input to VTA GABA neurons (Bocklisch et al., 2013; Faget et al., 2016; Kalivas et al., 1993; Watabe-Uchida et al., 2012; Xia et al., 2011) , it is somewhat surprising that rewardrelated behaviors by direct optogenetic stimulation of NAc terminals in the VTA had not been previously demonstrated. We suspect that the absence of reporting on NAc terminal stimulation using optogenetic manipulations may be due to the fact that researchers have focused on the NAcMed, which as we demonstrate, produces a generalized state of behavioral suppression instead of reward and is therefore not consistent with the disinhibition model. Instead, only when selectively stimulating NAcLat terminals in the VTA were we able to successfully induce a potent reward phenotype, which is likely caused by a disinhibition of NAcLat-projecting VTA DA neurons. However, other contributing factors such as the modulation of VTA GABA projection neurons (Laviolette and van der Kooy, 2001) or co-release of neuropepetides from the NAcLat (Xia et al., 2010 ) cannot be excluded. In contrast, when stimulating NAcMed terminals in the VTA, a reward phenotype is revealed only after infusion of the GABABR antagonist CGP35348 into the VTA. Activation of GABABRs in the VTA (e.g., through infusion of baclofen) has a reward-suppressing effect (Willick and Kokkinidis, 1995) and decreases DA output in the NAc (Pitman et al., 2014; Westerink et al., 1996; Xi and Stein, 1998) . Thus, NAcLat-projecting DA neurons are under strong, sustained inhibition from both long-range and local inputs, which is reflected in their high mIPSC frequency ( Figure 2) ; this might be necessary for an effective tonic suppression of DA neuron activity in the absence of salient or reward-predicting stimuli (Henny et al., 2012) . Surprisingly, however, infusion of CGP35348 into the VTA induced a reward phenotype when stimulating NAcMed terminals in the VTA (Figure 7) . If the rewarding phenotype after GABABR blockade is indeed caused by an inhibition of NAcMed-projecting DA neurons, which was the predominant net effect when activating these inputs, then this points to a fundamentally different role of NAcMed-projecting DA neurons underlying motivated behaviors. However, it is also possible Our data suggest that the mesolimbic DA system contains both indirect (1) and direct (2) feedback loops. Indirect: D1-expressing medium spiny neurons (MSNs) in the NAcLat predominantly target VTA GABA neurons, which exert inhibitory influence over NAcLat-projecting DA neurons. Thus, activation of the NAcLat pathway increases firing of NAcLat-projecting DA neurons through a net disinhibition. There also appears to be an indirect pathway from D1-expressing MSNs in the NAcMed to mVTA GABA neurons, which inhibit NAcMedprojecting DA neurons. However, NAcMed terminal stimulation in the VTA resulted in a net inhibition in most NAcMed-projecting DA neurons suggesting that the direct pathway from D1-expressing MSN in NAcMed to NAcMed-projecting DA neurons is stronger compared to the indirect pathway. Direct: D1-expressing MSNs in the NAcMed directly inhibit NAcMedprojecting DA neurons via GABAARs and NAcLat-projecting DA neurons via GABABRs. Thus, activation of the NAcMed pathway results in inhibition of both NAcMed-and NAcLat-projecting DA neurons. that optogenetic manipulations of NAc terminals in the VTA may result in backpropagating action potentials that activate other brain structures via axon collaterals. In addition, our stimulation pattern may not recapitulate physiological activity patterns in NAc neurons projecting to the VTA. Lastly, it is interesting that VGLUT2 is strongly co-expressed in NAcMed-projecting DA neurons ( Figure S6) . Thus, future studies need to delve deeper into the functional role of DA and glutamate co-release in the NAcMed. Despite these limitations, our results suggest that our perspective of the mesolimbic DA system needs to be more nuanced than traditional views that have often considered these cells as a homogeneous population. Emerging data require that we develop a new perspective on this circuitry that will guide future treatment strategies for addiction and other neuropsychiatric disorders where dysfunction of the neural systems underlying motivated behaviors have been strongly implicated.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
The following mouse lines (25-30 g, 8-12 weeks old, males and females were counterbalanced across conditions with no significant effects of sex observed) were used for the experiments: C57Bl6 mice (Jackson Laboratory), D1-Cre (GENSAT, stock number: 017264-UCD, strain code: Tg(Drd1-cre)EY262Gsat/Mmucd), A2a-Cre (GENSAT, stock number: 017263-UCD, strain code: Tg(Drd2-cre)ER44Gsat/Mmucd), GAD2-IRES-Cre (Jackson Laboratory, stock number: 010802, strain code: Gad2 tm2(cre)Zjh /J), 
Elevated Plus Maze
The elevated plus maze was made of plastic and consisted of two light gray open arms (30 3 5 cm) and two black enclosed arms (30 3 5 cm) extending from a central platform (5 3 5 3 5 cm) at 90 degrees in the form of a plus sign. The maze was placed 30 cm above the floor. Mice were initially placed in the center of the maze and allowed to freely explore, and video tracking software (Biobserve) was used to track their path. The 9-min session was divided into three 3-min epochs; during the first epoch, there was no light stimulation (off), during the second epoch there was light stimulation at 20 Hz (on), and during the third epoch there was no light stimulation (off). Light output during stimulation was the same as in the real-time place preference experiments, above. Optopharmacology Six D1-Cre mice were injected with AAV-DIO-ChR2-eYP into the NAcMed (see stereotactic surgeries for details) and implanted with a custom-made optofluidic system, which allowed precise drug infusion and optogenetic stimulation into the VTA (bregma, À3.4 mm, lateral, 0.5 mm, ventral, À3.8 mm). Mice received unilateral infusion of 1 mL sterile ACSF solution or 15 nM/mL CGP35348 in ACSF into the VTA. Infusions were made at a rate of 0.5 mL/min with a syringe pump (Harvard Apparatus) and were performed in the animal's home cages. After infusion, mice were allowed to spend 3 min in their home cage to allow the drugs to take effect before the behavioral sessions began. We first performed real-time place preference experiments (described above) starting with ACSF infusion, and 24h later CGP35348 infusion experiments were performed. Elevated plus maze experiments were performed 48h later using the procedures outlined above.
Histology and Confocal Microscopy
Immunofluorescence and confocal microscopy were performed as described previously . Briefly, after intracardial perfusion with 4% paraformaldehyde in PBS, pH 7.4, the brains were post-fixed overnight and coronal midbrain slices (50 or 100 mm) were prepared. The primary antibodies used were rabbit anti-tyrosine hydroxylase (TH, 1:1000, Millipore) and mouse anti-TH (1:1000, Millipore). The secondary antibodies used were Alexa Fluor 546 goat anti-rabbit, Alexa Fluor 546 goat anti-mouse, Alexa Fluor 647 goat anti-rabbit and Alexa Fluor 647 goat anti-mouse (1:750, Thermo Fisher Scientific). Image acquisition was performed with Zeiss LSM710 laser scanning confocal microscope using 20x or 40x objectives and on a Zeiss AxioImager M1 upright widefield fluorescence/differential interference contrast microscope with charge-coupled device camera using 5x objectives. Confocal images were analyzed using ImageJ. Sections were labeled relative to bregma using landmarks and neuroanatomical nomenclature as described in ''The Mouse Brain in Stereotaxic Coordinates'' (Franklin and Paxinos, 2001 ). For quantification of fluorescence intensities, confocal images were acquired using a 20x objective with identical pinhole, gain, and laser settings. 24 images from 3 different animals from medial and lateral VTA and from the same tissue sections were acquired at the same focal level. The medial and lateral VTA was defined as the area that corresponds to the anatomical location of distinct DA subpopulations . The medial VTA was defined as the region comprising the paranigral nucleus and interfascicular nucleus, whereas the lateral VTA was defined as the lateral parabrachial pigmented nucleus and the medial lemniscus adjacent to the substantia nigra. No additional post-processing was performed on any of the collected images. The fluorescence intensity for eYFP and mCherry expression was then quantified in each VTA subregion as the percentage per pixel using ImageJ software.
QUANTIFICATION AND STATISTICAL ANALYSIS
Student's t tests (paired and unpaired), Chi-square test, one-way or two-way ANOVA tests were used to determine statistical differences for anatomical, behavioral, and electrophysiological data using GraphPad Prism 6 (Graphpad Software). Tukey's post hoc test or Holm-Sidak's post hoc analysis was applied when ANOVA showed a significant main effect. Statistical significance was * p < 0.05, ** p < 0.01, *** p < 0.001. All data are presented as means ± SEM. Details of the statistical analysis per figure are summarized in Table S1 .
